Sai Life Sciences Limited (BOM:544306)
India · Delayed Price · Currency is INR 1,216.95
+10.40 (0.86%)
At close: Jun 19, 2026
Sai Life Sciences Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Sai Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of ₹1,275. The average 1-year stock price forecast is 4.77% higher than the current stock price, while the lowest is ₹1,225 (+0.66%) and the highest is ₹1,371 (+12.66%).
Price Target: ₹1,275 (+4.77%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Sai Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Financial Forecast
Revenue This Year
26.46B
from 21.92B
Increased by 20.66%
Revenue Next Year
32.50B
from 26.46B
Increased by 22.85%
EPS This Year
19.07
from 16.76
Increased by 13.79%
EPS Next Year
24.55
from 19.07
Increased by 28.76%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 27.2B | ||
| Avg | 26.5B | ||
| Low | 25.2B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 24.1% | ||
| Avg | 20.7% | ||
| Low | 15.0% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 19.68 | ||
| Avg | 19.07 | ||
| Low | 17.76 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 17.4% | ||
| Avg | 13.8% | ||
| Low | 6.0% |